TPMT and acute lymphoblastic leukemia: Although approximately 10% of the Caucasian population carries a nonfunctional sequence variant, its frequency is exceptionally low in Asian populations, which brought limits to the application of the TPMT genotype to regulating dose of 6-MP in Asian ALL patients [11].